Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model

BACKGROUND: Tetanus-reduced dose diphtheria-acellular pertussis (Tdap) vaccination during adolescence was introduced in response to the resurgence of pertussis in various countries. A new Tdap vaccine was manufactured in Korea as a countermeasure against a predicted Tdap vaccine shortage. This study...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :BMC Infect Dis
Главные авторы: Kwon, Hyo Jin, Han, Seung Beom, Kim, Bo Ram, Kang, Kyu Ri, Huh, Dong Ho, Choi, Gi Sub, Ahn, Dong Ho, Kang, Jin Han
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2017
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5381055/
https://ncbi.nlm.nih.gov/pubmed/28376777
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-017-2369-x
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы